Female low sexual desire – Reconnect (BMT-302)

Hypoactive sexual desire disorder (HSDD) refers to a woman’s chronic or ongoing lack of interest in sex, to the point that it causes her personal distress or problems in her relationships.

To evaluate the efficacy and safety of subcutaneously administered Bremelanotide (BMT) in pre-menopausal Women with Hypoactive Sexual Desire Disorder (HSDD).


Register Today!

Let others know about this Trial!

Trial Information

StatusOngoing
Start DateAugust 2015
End DateAugust 2018
Trial Duration2 Years
Number of Visits18
Lead CRCJessica Richer

For additional information
on this trial contact:

Phone705-566-0005